Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutation

This publication has 24 references indexed in Scilit:

• Germline Dinucleotide Mutation in Codon 883 of the RETProto-Oncogene in Multiple Endocrine Neoplasia Type 2B Without Codon 918 Mutation
  Journal of Clinical Endocrinology & Metabolism, 1997
• Germline mutation of RET codon 883 in two cases of de novo MEN 2B
  Oncogene, 1997
• The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2
  JAMA, 1996
• Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
  Human Molecular Genetics, 1993
• Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
  Nature, 1993
• Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entity
  British Journal of Surgery, 1986
• Mucosal ganglioneuromatosis, medullary thyroid carcinoma, and pheochromocytoma: Multiple endocrine neoplasia, type 2b
  Oral Surgery, Oral Medicine, Oral Pathology, 1976
• STUDY OF A KINDRED WITH PHEOCHROMOCYTOMA, MEDULLARY THYROID CARCINOMA, HYPERPARATHYROIDISM AND GUSHING ʼS DISEASE: MULTIPLE ENDOCRINE NEOPLASIA, TYPE 21
  Medicine, 1968
• Syndrome of Bilateral Pheochromocytoma, Medullary Thyroid Carcinoma and Multiple Neuromas
  New England Journal of Medicine, 1968
• The association of pheochromocytoma with carcinoma of the thyroid gland
  The American Journal of Medicine, 1961